Whighwatchers filed for bankruptcy in the United States because it struggled with fat-stinging debts such as Ozempic and Mounjaro.

The legal process will have $1.15 billion (£860 million) in the 60-year-old diet brand debt, while agreeing to repay the lender's new terms.

Weightwatchers said it will remain "fully running" and "no impact on members" during the process.

This is what the company calls “the rapid change in weight management situation” in the rapid growth of traffic weight loss injections.

"For over 62 years, Weightwatchers has authorized millions of members to make informed, healthy choices that remain resilient as the trend develops."

The plans have “overwhelming support from our lenders,” she said.

The brand said in a statement that its weight loss program, “Telehealth” program will continue.

The company vowed to "stay here" and did not go bankrupt.

It said it "has a lot of debt on its balance sheet, some of which date back decades," and filing for bankruptcy will allow it to restructure its balance sheet.

The company added that some clients will receive court notice as part of the process, but they do not need to take any action.

The weight watch started as a weekly weight loss group meeting with 400 attendees and eventually attracted millions of members around the world.

But demand for its plans has declined, and the popularity of weight loss drugs such as Wegovy and Zepbough has risen - although the brand does sell weight drugs as part of its plans.

In February, Ms. Comonte said a weight watch could help people seeking “sustainable” weight loss take medication.

“At the same time, as we navigate the industry and reposition the long-term growth, there is a major transition period in weight watches,” she said.

The brand reported a net loss of $346 million (£260 million), while its subscription revenue fell 5.6% from the previous year.

On Tuesday, it reported that subscription revenue fell 9.3% in the first three months of 2025 - although revenue from its clinical business, including weight loss drugs, increased by more than 57%.

The brand's total liabilities are $18.8 billion greater than its asset value. It said, "The restructuring plan is expected to be confirmed within about 40 days and become a publicly traded company."

WeightWatchers was renamed “WW” in 2018 because it focuses on promoting health outside of weight loss range.